The paper focuses on the pharmaceutical policy of the first two year period of the Trump Administration. Particularly, it focuses on the attempt to to repeal and replace Obamacare and on the news of the Blueprint Program.
Pharmaceutical Policies after the First Two Years of President Trump
Anna Ciammariconi
2019-01-01
Abstract
The paper focuses on the pharmaceutical policy of the first two year period of the Trump Administration. Particularly, it focuses on the attempt to to repeal and replace Obamacare and on the news of the Blueprint Program.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
